MedElevator Войти в исследования
← Поиск публикаций

DOI 10.2174/1871520618666181029170605

Медицинская библиотека · Anti-cancer agents in medicinal chemistry · 2019

Cyclosporine A Suppresses the Malignant Progression of Oral Squamous Cell Carcinoma in vitro.

Gao Ling, Dong Jianwei, Zhang Nanyang, Le Zhanxian, Ren Wenhao, Li Shaoming, Li Fan, Song Jianzhong, Wang Qibo, Dou Zhichao, Park Soo Y, Zhi Keqian

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

The Oral Squamous Cell Carcinoma (OSCC) is one of the most frequent cancer types. Failure of treatment of OSCC is potentially lethal because of local recurrence, regional lymph node metastasis, and distant metastasis. Chemotherapy plays a vital role through suppression of tumorigenesis. Cyclosporine A (CsA), an immunosuppressant drug, has been efficiently used in allograft organ transplant recipients to prevent rejection, and also has been used in a subset of patients with autoimmunity related disorders. The present study aims to investigate novel and effective chemotherapeutic drugs to overcome drug-resistance in the treatment of OSCC.

METHODS

Cells were incubated in the standard way. Cell viability was assayed using the MTT assay. Cell proliferation was determined using colony formation assay. The cell cycle assay was performed using flow cytometry. Apoptosis was assessed using fluorescence-activated cell sorting after stained by the Annexin V-fluorescein isothiocyanate (FITC). Cell migration and invasion were analyzed using wound healing assay and tranwell. The effect of COX-2, c-Myc, MMP-9, MMP-2, and NFATc1 protein expression was determined using Western blot analysis while NFATc1 mRNA expression was determined by RT-PCR.

RESULTS

In vitro studies indicated that CsA inhibited partial OSCC growth by inducing cell cycle arrest, apoptosis, and the migration and invasion of OSCC cells. We also demonstrated that CsA could inhibit the expression of NFATc1 and its downstream genes COX-2, c-Myc, MMP-9, and MMP-2 in OSCC cells. Furthermore, we analyzed the expression of NFATc1 in head and neck cancer through the Oncomine database. The data was consistent with the experimental findings.

CONCLUSION

The present study initially demonstrated that CsA could inhibit the progression of OSCC cells and can mediate the signal molecules of NFATc1 signaling pathway, which has strong relationship with cancer development. That explains us CsA has potential to explore the possibilities as a novel chemotherapeutic drug for the treatment of OSCC.

Для цитирования: Gao Ling, Dong Jianwei, Zhang Nanyang, Le Zhanxian, Ren Wenhao, Li Shaoming, Li Fan, Song Jianzhong, Wang Qibo, Dou Zhichao, Park Soo Y, Zhi Keqian. Cyclosporine A Suppresses the Malignant Progression of Oral Squamous Cell Carcinoma in vitro.. Anti-cancer agents in medicinal chemistry. 2019. DOI: 10.2174/1871520618666181029170605.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.